|
ITPRIPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.260430E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.168200E-01 |
| Normal-vs-Stage2 |
2.384800E-01 |
| Normal-vs-Stage3 |
8.353800E-01 |
| Normal-vs-Stage4 |
8.418000E-01 |
| Stage1-vs-Stage2 |
6.818400E-01 |
| Stage1-vs-Stage3 |
6.493800E-01 |
| Stage1-vs-Stage4 |
4.666000E-01 |
| Stage2-vs-Stage3 |
5.219400E-01 |
| Stage2-vs-Stage4 |
4.751200E-01 |
| Stage3-vs-Stage4 |
7.490600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.389800E-02 |
| Normal-vs-AfricanAmerican |
8.164800E-01 |
| Normal-vs-Asian |
2.718000E-01 |
| Caucasian-vs-AfricanAmerican |
1.565570E-01 |
| Caucasian-vs-Asian |
1.929580E-01 |
| AfricanAmerican-vs-Asian |
3.864400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.140400E-01 |
| Normal-vs-Female |
8.664200E-02 |
| Male-vs-Female |
3.500200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.805600E-01 |
| Normal-vs-Extreme_Weight |
3.314600E-01 |
| Normal-vs-Obese |
1.651800E-01 |
| Normal-vs-Extreme_Obese |
5.557200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.612200E-01 |
| Normal_Weight-vs-Obese |
3.190200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.360400E-01 |
| Extreme_Weight-vs-Obese |
6.247200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.804000E-01 |
| Obese-vs-Extreme_Obese |
2.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.833200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.050780E-01 |
| Normal-vs-Age(61-80Yrs) |
1.424360E-01 |
| Normal-vs-Age(81-100Yrs) |
6.555600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.414300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.655800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.005400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.245800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.692500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.472100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.754390E-01 |
| Normal-VS-Type2 PRCC |
7.095200E-01 |
| Normal-VS-KIRP CIMP |
9.53759999999804E-05 |
| Normal-VS-Unclassified PRCC |
4.266200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.816000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.19589999967052E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.806840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.91589999999043E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.760300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.22339999972543E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.211200E-01 |
| Normal-vs-N1 |
4.960600E-01 |
| Normal-vs-N2 |
3.859600E-01 |
| N0-vs-N1 |
2.700200E-01 |
| N0-vs-N2 |
5.652600E-01 |
| N1-vs-N2 |
4.608000E-01 |
|
|
